Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Siemens Next Generation Technology May Bring New Hope To Cancer Patients

18.06.2008
First patients are treated with the new ARTISTE Solution Linear Accelerator in Germany, the Netherlands, and the United States

The ARTISTE™ Solution from Siemens has recently gone clinical in three of the most prominent cancer centers around the world. Dozens of patients have been treated to date at MAASTRO Clinic in the Netherlands, German Cancer Research Center (DKFZ) in Heidelberg, Germany, and Baton Rouge General’s Pennington Cancer Center in Louisiana.


The ARTISTE Solution is a linear accelerator engineered specifically for Adaptive Radiation Therapy (ART). Unique in design, ARTISTE is an integrated imaging and workflow solution that offers a comprehensive portfolio of image-guided and advanced treatment delivery protocols, including in-room CT imaging capabilities and a new multileaf collimator, 160 MLC.

One of the first patients treated with ARTISTE was seen at DKFZ, where the linear accelerator was used to administer radiotherapy for an inoperable esophagus tumor. “Treatment for this type of tumor demands a very complicated radiotherapy approach,” said Prof. Dr. Huber, head of the Radiation Oncology Clinical Cooperation Unit at DKFZ. “Using ARTISTE’s 160 MLC™ Multileaf Collimator, we were able to significantly improve the precision of the dose delivery while protecting immediate surrounding healthy tissue.”

That same week, several patients at MAASTRO Clinic were also treated using ARTISTE. A couple of challenging clinical cases included a metastasized tumor in the abdominal region and a patient with two separate metastases: one in the head and neck region, and one in the knee cap.

“The advanced, high-end imaging capabilities of ARTISTE allow us to fully integrate all our Image-Guided Radiation Therapy (IGRT) and MAASTRO-developed Dose-Guided Radiation Therapy (DGRT) methods in one clinical workflow. ARTISTE’s imaging flexibility and simplified workflow help us to confidently treat proliferated tumors in a wide range of areas of the body,” said Bas Nijsten, medical radiotherapy physicist in the Maastricht Radiation Oncology Department.

More recently, the first U.S. patients were treated with ARTISTE Solution at the Baton Rouge General’s Pennington Cancer Center. The first two patients were treated for lung and prostate tumors, respectively, where ARTISTE’s 2D and 3D imaging allowed confirmation of tumor location and enabled more focused and aggressive treatment while helping spare organs at risk.

“With ARTISTE, Siemens is changing the way radiotherapy is delivered. As the first site in the U.S. with ARTISTE, our mission at Baton Rouge General’s Pennington Cancer Center is to combine our commitment to compassionate cancer care with the latest, most advanced treatment technology,” said Dr. William Russell, medical director of Radiation Oncology at Pennington Cancer Center.

“This exciting milestone has come to fruition thanks to the clinical collaboration between Siemens, MAASTRO, DKFZ, and Baton Rouge General,” said Holger Schmidt, CEO, Oncology Care Systems, Siemens Medical Solutions USA, Inc. “ARTISTE’s unique integration of technologies and streamlined workflow allows clinicians to truly customize patient treatment by providing them the flexibility and means to confidently optimize treatment on a per-patient basis. It is an honor for us at Siemens to be part of this collaborative effort to help improve quality of care for cancer patients around the world. We are delighted to call 55 new ARTISTE orders since its introduction in the market last January.” The goal of Adaptive Radiation Therapy (ART) is to ensure the therapeutic dose is delivered precisely to the target, and healthy tissue is spared as planned. To achieve this goal, it is necessary to image the patient just prior to treatment, verify that the patient position is correct, and adapt to any anatomical changes immediately before, or even during, treatment.

About Siemens Healthcare

The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care – from prevention and early detection, to diagnosis, therapy and care.

Additionally, Siemens is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion, orders of €10.27 billion, and group profit of €1.32 billion. Further information can be found by visiting http://www.siemens.com/healthcare.

About Baton Rouge General’s Pennington Cancer Center

Baton Rouge General’s Pennington Cancer Center has a rich history of bringing advanced cancer treatment solutions to South Louisiana through its comprehensive, multidisciplinary cancer program which includes inpatient, outpatient, surgical and medical oncology services; radiation treatment; and cancer research programs. In 2006, the Pennington family endowed Baton Rouge General’s cancer center, further expanding and increasing access to high quality cancer treatment for the people of this region. For further information, visit http://www.brgeneral.org

About DKFZ

The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The findings resulting from basic research are expected to lead to new approaches in the prevention, diagnosis, and treatment of cancer. Funding is provided by the Federal Ministry of Education and Research (BMBF; 90 percent) and by the State of Baden-Wuerttemberg (10 percent). The German Cancer Research Center is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V.) Further information can be found at www.dkfz.de.

About MAASTRO CLINIC

MAASTRO, Maastricht Radiation Oncology, is a co-operation between MAASTRO clinic, the University of Maastricht (UM) and the University Hospital Maastricht (azM). MAASTRO clinic offers state-of-the-art radiotherapy to more than 3,500 cancer patients each year from the mid- and South Limburg area in the Netherlands. MAASTRO clinic currently has seven modern linear accelerators, all equipped with EPID and one with Megavolt Cone Beam CT, a PET-CT and a small and large bore multislice CT with 4D-CT option. For all patients, planning is done via virtual simulation and 3D planning software, using advanced dose calculation algorithms. Stereotactic and brachytherapy treatment are also offered by MAASTRO clinic. The department’s ambitions focus on individualizing treatment using Computer Assisted Theragnostics (CAT), developing predictive models for lung cancer, implementing Dose Guided Radiation Therapy (DGRT) and fundamental biological research on tumor hypoxia. Long-term strategies are defined in the areas of ion therapy, smart drugs based on EGFR-AKT pathway, and stem cells and probabilistic voxel guided radiotherapy. Furthermore, MAASTRO is a world-wide research partner based reference site for Siemens OCS.

Tom Schaffner | Siemens Healthcare
Further information:
http://www.siemens.com/healthcare

More articles from Medical Engineering:

nachricht Biocompatible 3-D tracking system has potential to improve robot-assisted surgery
17.02.2017 | Children's National Health System

nachricht Real-time MRI analysis powered by supercomputers
17.02.2017 | University of Texas at Austin, Texas Advanced Computing Center

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Biocompatible 3-D tracking system has potential to improve robot-assisted surgery

17.02.2017 | Medical Engineering

Real-time MRI analysis powered by supercomputers

17.02.2017 | Medical Engineering

Antibiotic effective against drug-resistant bacteria in pediatric skin infections

17.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>